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Abstract: Microcystins (MC) are potent hepatotoxins produced by the cyanobacteria of the 
genera  Planktothrix,  Microcystis,  Aphanizomenon,  Nostoc  and  Anabaena.  These  cyclic 
heptapeptides have strong affinity to serine/threonine protein phosphatases (PPs) thereby 
acting as an inhibitor of this group of enzymes. Through this interaction a cascade of 
events responsible for the MC cytotoxic and genotoxic effects in animal cells may take 
place.  Moreover  MC  induces  oxidative  stress  in  animal  cells  and  together  with  the 
inhibition of PPs, this pathway is considered to be one of the main mechanisms of MC 
toxicity.  In  recent  years  new  insights  on  the  key  enzymes  involved  in  the  
signal-transduction and toxicity have been reported demonstrating the complexity of the 
interaction  of  these  toxins  with  animal  cells.  Key  proteins  involved  in  MC  up-take, 
biotransformation and excretion have been identified, demonstrating the ability of aquatic 
animals  to  metabolize  and  excrete  the  toxin.  MC  have  shown  to  interact  with  the 
mitochondria. The consequences are the dysfunction of the organelle, induction of reactive 
oxygen  species  (ROS)  and  cell  apoptosis.  MC  activity  leads  to  the  differential 
expression/activity of transcriptional factors and protein kinases involved in the pathways 
of cellular differentiation, proliferation and tumor promotion activity. This activity may 
result from the direct inhibition of the protein phosphatases PP1 and PP2A. This review 
aims to summarize the increasing data regarding the molecular mechanisms of MC toxicity 
in animal systems, reporting for direct MC interacting proteins and key enzymes in the 
process of toxicity biotransformation/excretion of these cyclic peptides. 
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1. Introduction  
Cyanobacteria are photoautotrophic bacteria commonly found in fresh and brackish waters all over 
the globe. The cyanobacteria in eutrophic waters and under specific environmental conditions can 
grow  excessively,  producing  blooms.  Cyanobacteria  growth  is  a  natural  phenomenon,  but  it  is 
becoming  more  frequent  and  severe  as  a  result  of  anthropogenic  activity.  One  particularity  of 
cyanobacteria is the production of secondary metabolites which are toxic to other organisms. These 
toxins under situations of excessive cyanobacterial growth can be accumulated in aquatic wildlife and 
transferred  to  higher  trophic  levels  with  the  risk  of  livestock  and  human  poisoning.  Therefore 
cyanobacterial blooms are regarded as a serious human health issue [1], also having a strong impact on 
wildlife [2,3]. 
The  microcystins  (MC),  produced  by  species  of  the  genera  Planktothrix,  Microcystis, 
Aphanizomenon, Nostoc and Anabaena [4], are among the most frequently detected in fresh waters, 
and produce potent toxic effects. The general structure of microcystin (MC) is cyclo-(D-Ala1-X2-D-
MeAsp3-Z4-Adda5-D-Glu6-Mdha7), where X and Z are variable L-amino acids, D-MeAsp represents 
D-erythro-β-methylaspartic  acid,  Adda  the  unusual  amino  acid  (2S,3S,8S,9S)-3-amino-9-methoxy-
2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid and Mdha N-methyldehydroalanine [4] (Figure 1).  
Figure 1. General structure of microcystin, adapted from McElhiney and Lawton [5]. In 
MC-LR X represents L-Leucine; Z L-Arginine; R1 and R2 CH3. 
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Nevertheless  there are identified over 80 variants of this molecule  [6]  including  amino acid 
variations and modifications. The molecular weight of MC varies between 900 and 1 ,100 Daltons. 
Amino acid variations in positions X and Y account for many of the MC variants. The most common 
are MC-LR, MC-RR and MC-YR, with different combinations of leucine (L), arginine (R) or tyrosine 
(Y) [7]. MC-LR is the most studied due to its ubiquity, abundance and toxicity  [8]. The Adda moiety, 
present in all variants, is critical to MC activity  [9]. Its isomerization and/or oxidation dramatically Int. J. Mol. Sci. 2010, 11                       
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reduces  the  toxicity [10].  Microcystins  inhibit  serine/threonine-specific  protein  phosphatases  (PPs) 
such as PP1 and PP2A through the binding to these enzymes [11,12]. The acute toxicity of MC can be 
explained by this phosphatase inhibition which leads to an excessive phosphorylation of proteins and 
to alterations in cytoskeleton, loss of cell shape with subsequent destruction of liver cells causing intra-
hepatic haemorrhage or hepatic insufficiency [4]. MC are also responsible for the increase of oxidative 
stress in cells which subsequently can trigger apoptotic processes [8,13]. These molecules have been 
regarded also as tumor promoters [14–18].  
Human health problems are most likely related with chronic exposure to low MC concentrations 
through  consumption  of  contaminated  waters  and  food  (agricultural  products,  fish,  prawns,  and 
mollusks),  dermal  exposure  and  inhalation.  Liver  is  the  most  affected  organ  in  humans  but  the 
exposure to the toxin is likely to affect organs such as kidney and colon as evidenced by in vivo [19–22] 
and in vitro studies [23,24]. Therefore the illnesses attributed to MC intoxication are gastroenteritis 
and related diseases, allergic and irritation reactions, and liver diseases. Some lesions can evolve into 
tumors and primary liver cancer and colorectal cancers in human populations have been related with 
MC  exposure  and  toxicity [25–27].  It  is  important  to  bear  in  mind  that  MC  effects  are  time  and 
concentration dependent [28]. 
The MC are non-ribosomal peptides synthesized by a multi-functional protein complex containing 
non-ribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) domains [29]. This multi-
functional protein complex is present only in prokaryotes and lower eurakyotes [29] and is encoded by 
large bacterial gene clusters which comprises at least two operons, the mcyABC (peptide synthetase) 
and mcyDE (hybrid polyketide-peptide synthetase) [30]. Although the toxin can be localized in all 
regions in the interior of cyanobacteria cells, it was suggested that most of cell’s toxin complement is 
localized  in  the  thylakoids,  followed  by  the  nucleoplasm  and  pyrophosphate  bodies [31].  The 
association of MC to the thylakoids might occur through the hydrophobic ADDA moiety inserted in 
the membrane and the polar cyclic structure interacting with cytoplasm. This preferential localization 
suggests  that  the  molecule  may  play  an  important  role  in  light  harvesting  and  adaptation 
responses [29]. MC can reach intracellular concentration far above the limit of solubility in water. For 
this reason it was recently suggested that this high concentration in Microcystis cells can be reached by 
MC binding to phycobilins [32].  
The molecular mechanisms of microcystins toxicity are being investigated and advances have been 
reached  in  the  knowledge  of  the  activity  of  this  cyclic  peptide  at  cellular  and  molecular  level. 
Moreover  the  molecular  basis  of  MC  biotransformation  is  being  elucidated.  This  review  aims  to 
analyze  the  information  published  so  far  regarding  the  molecular  aspects  of  MC  toxicity  and  
bio-transformation in animal systems. A summary of the main proteins reported and their roles in MC 
mediated cell injury is presented in the Table 1. Int. J. Mol. Sci. 2010, 11                       
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Table 1. List of proteins expressed in animal cells with functions in the processes of MC 
up-take, toxicity and biotransformation. 
      MC toxicity 
Protein  Activity  Biological 
function  Presence of MC  Experimental 
approach  References 
PP1, PP2A 
 
 
 
serine/threonine 
protein 
phosphatase 
regulation of 
protein activity 
inhibition of 
activity 
MC-PP 
interactions 
[11,42] 
DNA-PK 
 
 
 
 
 
serine/threonine 
protein kinase 
DNA repair  decrease activity  activity of DNA 
repair synthesis 
from cell extracts 
and purified 
DNA-PK 
[49,51] 
CaMKII 
 
 
 
serine/threonine 
protein kinase 
cell signalling  increase in 
activity 
exposure of 
primary 
hepatocytes to 
MC 
[56] 
NeK2 
 
 
 
serine/threonine 
protein kinase 
cell signaling  increase in 
activity 
activity of 
purified 
NeK2:PP1 
complex  
[58] 
P53 
 
 
 
 
 
 
transcription 
factor 
cell cycle, tumor 
supression 
increase of 
protein/gene 
expression 
exposure of 
HepG2, FL cell 
lines, primary 
hepatocytes and 
in vivo liver 
tissues to MC 
[59,61,62] 
Bcl-2 
 
 
 
 
 
 
regulation of 
mitochondrial 
apoptosis-induced 
channel (MAC) 
mitochondrial 
outer membrane 
permeabilization, 
apoptosis 
decrease of 
protein/gene 
expression 
exposure of 
primary 
hepatocytes, in 
vivo liver tissues 
and FL cells to 
MC 
[59,61] 
MAPKs 
 
 
 
 
serine/threonine 
protein kinase 
signal 
transduction, cell 
proliferation and 
differentiation 
increase of gene 
expression 
exposure of 
HEK293-
OATP1B3 cell 
line to MC 
[67] 
NADPH oxidase 
 
 
 
electron transfer 
to superoxide 
production of 
ROS 
increase of gene 
expression 
exposure of 
HepG2 cell line 
to MC 
[69] 
Bax, Bid 
 
 
 
 
regulation of 
mitochondrial 
apoptosis-induced 
channel (MAC) 
mitochondrial 
outer membrane 
permeabilization, 
apoptosis 
increase of 
protein 
expression 
in vivo exposure 
of liver tissues to 
MC 
[73] 
JNK 
 
 
MAPK  signal 
transduction, cell 
proliferation and 
differentiation 
increase in 
protein 
expression 
in vivo exposure 
of liver tissues to 
MC  
[74] 
IL-8, CINC-2αβ, 
L-selectin, β2-
integrin 
chemotactic 
cytokines 
chemotaxis, 
inflammatory 
reactions 
increase in 
protein/gene 
expression 
in vitro exposure 
of neutrohils to 
MC 
[88,89] 
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Table 1. Cont. 
OATP 
 
 
 
 
 
 
plasma membrane 
transporter 
transport of 
organic anions  
nd 
(a)  exposure of 
transfected 
Xenopus laevis 
oocytes and 
Oatp1b2-null 
mice to MC 
[36,38] 
GST 
 
 
 
gluthatione S-
transferase 
metabolism of 
endogenous 
compounds and 
xenobiotics 
differential 
expression of 
GST genes 
in vivo exposure 
of fish liver 
tissues to MC  
[96,97] 
P-glycoprotein 
 
 
 
 
 
plasma membrane 
transporter 
cellular excretion 
of cytotoxic 
compounds 
increase of gene 
expression and 
protein activity 
in vivo exposure 
of fish liver, gills 
and brain tissues; 
fresh water 
mussel to MC 
[100,101] 
(a) Not determined. 
2. Cellular Uptake of MC 
MCs  cannot  readily  diffuse  through  plasma  membrane  due  to  the  high  molecular  weight  and 
structure. It is also known that due to the cell specificity and organotropism of MC-LR, selective 
pathways  of  MC  up-take  might  exist.  Ericksson  et  al. [33]  studied  the  cellular  up-take  of  a 
radiolabelled derivative of MC-LR in isolated rat hepatocytes, human hepatocarcinoma cell line Hep 
G2 and the mouse fibroblast cell line NIH-3T3. The up-take was shown to be specific of hepatocytes. 
Moreover by means of a surface barostat technique the authors showed that the membrane penetrating 
capacity  (surface  activity)  of  MC-LR  is  low,  indicating  that  the  toxin  requires  an  active  uptake 
mechanism. The inhibition of MC up-take by the use of inhibitors of the bile acid transporters further 
suggested the requirement of this system for MC to enter the cells [33]. In fact many transporters are 
responsible for the uptake of endogenous and exogenous chemicals into liver, including the organic 
anion transporting polypeptides (Oatps), Nat-taurocholatecotransporting polypeptide (Ntcp), organic 
anion transporters (Oats), and organic cation transporters [34]. Among these transporters, the Oatps are 
thought  to  be  responsible  for  the  majority  of  hepatic  uptake  of  chemicals,  whereas  Ntcp  mainly 
transports  bile  acids  into  liver [35].  Recently  Fischer  et  al. [36],  using  the  Xenopus  laevis  oocyte 
expression  system,  studied  the  transport  of  MC-LR  by  different  members  of  the  organic  anion 
transporting polypeptide superfamily (rodent: Oatps; human: OATPs). The authors verified that rat 
Oatp1b2, human OATP1B1, human OATP1B3, and human OATP1A2 transport MC-LR 2- to 5-fold 
above water-injected control oocytes. MC-LR transport was inhibited by co-incubation with the known 
Oatp/OATP substrates taurocholate (TC) and bromosulfophthalein (BSP). No MC-LR transport was 
observed  in  oocytes  expressing  other  Oatp  members  (Oatp1a1,  Oatp1a4,  and  OATP2B1), 
demonstrating in this way the MC specificity for rat Oatp1b2, human OATP1B1, human OATP1B3, 
and human OATP1A2. The OATP is a multispecific transport system expressed in diverse cell types 
such  as  enterocytes,  hepatocytes  and  renal  epithelial  cells [6]  and  organs  such  as  the  heart,  lung, 
spleen, pancreas, brain and blood-brain-barrier (BBB) [6]. Systemic distribution of MC in the organs 
will be therefore dependent on the degree of blood perfusion and types and expression level of OATP Int. J. Mol. Sci. 2010, 11                       
 
 
273 
carriers.  OATP1B1  and  1B3  are  human  liver  specific  while  OATP1A2  is  highly  expressed  in 
endothelial cells of the BBB, epithelial cells of the blood-cerebrospinal-fluid-barrier (BCFB) and in the 
cell membrane of human neurons [6]. Homologous to human OATP genes have been found in most 
diverse  animals,  some  being  related  with  the  transport  of  xenobiotics  including  MC [37].  The 
importance  of  OATP  system  in  MC  toxicity  was  evidenced  in  Oatp1b2-null  mice  engineered  by 
homologous recombination. Three hours after administration of microcystin-LR the binding of the 
cyclic peptide to the hepatic protein phosphatase 1/2a was much lower in Oatp1b2-null mice compared 
with wild-type mice. Livers of wild-type mice presented extensive hemorrhagic necrosis and elevated 
serum levels of both ALT and ALP also mortality was registered. Nevertheless Oatp1b2-null mice 
demonstrated complete resistance to hepatotoxicity induced by MC-LR [38].  
3. Toxicity Mechanisms  
3.1. Interaction with Protein Phosphatases PP1 and PP2A 
One of the most studied pathways of MC activity is the inhibition of serine/threonine protein 
phosphatases  by  interacting  with  the  catalytic  subunits  of  these  enzymes [39].  Protein 
phosphorylation/dephosphorylation is a dynamic process and an important pathway for the regulation 
of  protein  activity  in  cells.  It  is  catalyzed  by  phosphatases  and  kinases.  Therefore  uncontrolled 
inhibition  of  these  enzymes  can  have  significant  impact  in  cell’s  homeostasis.  MC  have  a  strong 
affinity to PP1 and PP2A types but have little effects on PP2B [40,41]. The interaction of MC-LR with 
PP1 and PP2A was reported as a two step mechanism, where the toxin first binds to the enzyme 
inactivating it and subsequently forms covalent adducts during prolonged reaction-time [11,42]. The 
determination  of  the  crystal  structure  of  MC-LR  binding  to  PP1  and  PP2A  was  important  to 
understand the nature of the interactions and the enzyme inhibition. MC-LR binds to the PP-1c α 
isoform through interactions at three sites of the enzyme, the hydrophobic groove, C-terminal groove 
and the catalytic site [43]. MC-LR coordinates with the two catalytic metal atoms of the phosphatase 
indirectly by binding two water molecules through the α-carboxyl group of its γ-linked D-glutamic 
acid moiety and the adjacent carbonyl oxygen. Therefore the glutamic acid α-carboxyl group plays a 
significant role in the toxicity of the cyclic peptide. The carboxyl group of the MeAsp residue of  
MC-LR interacts with Arg96 and Tyr134 of PP-1c blocking the access to the active centre of the 
enzyme [44]. Moreover the long hydrophobic tail, composed of the Adda residue interacts with the 
hydrophobic groove region of PP-1c, adjacent to the active site. Interactions can also occur at the 
toxin-sensitive b12–b13 loop (residues 268–281) of PP-1c. The crystal structure showed the covalent 
linkage between the Mdha side-chain of the toxin and the Cys-273 of PP-1c confirming the previous 
biochemical analyses. The crystal structure of MC-LR interacting with PP2A was described by Xing  
et al. [45]. The authors reported the binding of the toxin to the surface pocket of PP2A located above 
the  two  manganese  atoms  and  the  active  site  of  the  enzyme.  The  binding  is  strengthened  by 
hydrophobic interactions between the Adda side chain of MC-LR and the residues Gln122, Ile123, 
His191, and Trp200 of the binding pocket, by van der Waals interactions with the hydrophobic portion 
of the toxin and the residues Leu243, Tyr265, Cys266, Arg268, and Cys269 of the binding pocket and, 
by a covalent linkage between the Sγ atom of Cys269 and the terminal carbon atom of the Mdha side Int. J. Mol. Sci. 2010, 11                       
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chain [45]. The pathways involved in MC toxicity can be suggested by knowing the functions of PP1 
and PP2A and their protein substrates. PP2A has been regarded as an important tumor suppressor. 
Much of this evidence results from the observation that the enzyme is inactivated by the potent tumor 
inducer okadaic acid and that mutations, modifications, gain or loss of activity, in the distinct subunits 
of the enzyme have been linked to the development of cancer cells [45]. Moreover the well known 
effect of MC on liver tissue organization, hepatocyte morphology and cytoskeleton structure/dynamics 
has  been  related  with  PP1/PP2A  activity  and  increase  in  phosphorylation  of  cytoskeleton  
proteins [46–48], pointing out the role of these enzymes in the MC mediated acute toxicity and the 
importance of the identification of PP substrates for a comprehensive characterization of the pathways 
of MC action. In the next section of this review we will report the alterations in the activity/expression 
of phosphoproteins linked to MC mediated PP inhibition. The pathways of toxicity related with PP 
inhibition are represented in Figure 2. 
Figure 2. Suggested pathways of MC up-take, toxicity, biotransformation and excretion in 
animal cells. 
 
3.2. Regulation of Activity/Expression of Phosphoproteins 
Two pathways of DNA repair, the nucleotide excision repair (NER) and the DNA double strand 
break (DSB) repair by the nonhomologous end joining (NHEJ) have been shown to be inhibited by 
MC,  pointing  out  the  genotoxic  attributes  of  the  toxin [49,50].  Both  pathways  are  regulated  by 
phosphorylation and in vitro experiments demonstrated that PP1 and PP2A inhibition by significantly 
decreases the activity of the DNA repair systems [49,51]. Moreover the inhibition of the DSB-NHEJ is Int. J. Mol. Sci. 2010, 11                       
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due to the phosphorylation-induced loss of the protein kinase activity of the DNA-dependent protein 
kinase  (DNA-PK),  through  the  direct  inhibition  of  PP2A  like  enzymes [49].  The  DNA-PK  is  a 
complex  composed  of  a  catalytic  subunit  (DNA-PKcs)  and  the  DNA  end-binding  Ku70/Ku80 
heterodimer. All three subunits undergo phosphorylation in vitro and in vivo [49]. 
The  calcium-calmodulin-dependent  multifunctional  protein  kinase  II  (CaMKII)  is  activated  by 
Ca
2+/calmodulin, autophosphorylation and limited proteolysis. CaMKII can be activated by caspases 
thereby contributing to the downstream events in apoptosis. Fladmark et al. [52,53] first reported that 
PP-inhibitor-induced protein  phosphorylation in hepatocytes and  apoptosis require active  CaMKII. 
Ding et al. [54,55] postulated that the enzyme plays a role in the late events of MC induced cell death, 
being  activated  through  the increase  of  intracellular  Ca
2+. In  an  attempt  to  elucidate  whether  this 
enzyme acts upstream or downstream of the commitment point of cell death, Krakstad  et al. [56] 
screened cells for later morphological and functional signs of cell death , after adding cell-penetrating 
CaMKII inhibitors to microcystin-treated hepatocytes in pre-apoptotic stages. The authors verified that 
CaMKII-dependent commitment point precedes a putative reactive oxygen species (ROS) commitment 
point,  suggesting  that  CaMKII  activation  occur  upstream  ROS  formation.  CaMKII  activation  is 
achieved  by  inhibition  of  its  dephosphorylation.  This  might  be  under  control  of  MC  through  the 
inhibition of PP1 and PP2A (Figure 2). CaMKII activation might further regulate downstream events 
such as ROS formation and phosphorylation of proteins including myosin light chain (MLC) [56]. 
The Nek2, a member of the NIMA-related serine/threonine kinase family, is a cell cycle dependent 
protein kinase that participates in the control of mitotic progression and chromosome segregation. 
Expression of this protein has been related with a wide variety of human cancers [57]. The Nek2 
kinase forms a complex with the PP1 holoenzyme. The protein is activated by autophosphorylation but 
is inactivated by constant PP1 dephosphorylation within the complex [58]. The PP1 inhibitor-2 (I-2) 
protein activates the kinase by binding to the Nek2::PP1 complex. In in vitro assays MC-LR binds to 
the complex leading to similar activation of Nek2 kinase [58]. Likewise this biochemical interaction 
can  occur  at  the  cellular  level  with  implications  in  the  viability  of  cells,  tissue  injury  and  
tumor development. 
The  nuclear  phosphoprotein  P53  is  induced  in  response  to  cellular  stress.  It  plays  a  role  as  a 
transcriptional trans-activator in DNA repair, apoptosis and tumor suppression pathways [59]. The 
protein is a substrate of PP2A [60] and therefore its activity is likely to be regulated, in part, by  
MC-LR. Although the MC-LR mediated P53 regulation via PP2A has not been demonstrated the toxin 
leads to an increase in expression of p53 gene/protein in apoptotic HepG2 cells, cultured hepatocytes, 
rat liver tissues and FL cells [59,61,62]. P53 is a regulator of the expression of the anti- and pro-
apoptotic genes including members of the Bcl-2 family such as Bcl-2 and Bax. These proteins are 
potential  players  in  p53  induced  cell  apoptosis  through  the  involvement  in  the  outer-membrane-
permeabilization  transition  (MPT)  of  the  mitochondria,  thereby  triggering  the  process  of 
apoptosis [63]. Significant increase in the expression of cell-cycle regulation and cellular proliferation 
genes were observed in the liver of homozygous p53 deficient knockout mice treated with MC-LR, in 
comparison to age-matched wild-type controls [64]. Moreover livers from the Trp53-deficient, MC-LR 
group  displayed  greater  hyperplastic  and  dysplastic  changes  as  well  as  increases  in  Ki-67  and 
phosphohistone H3 (mitotic marker) immunoreactivity. This work indicates that p53 has an important 
function  in  preventing  the  proliferative  response  and  tumor  promotion  associated  with  chronic, Int. J. Mol. Sci. 2010, 11                       
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sublethal MC-LR exposure [64]. It is probable that p53 is activated in cells exposed to the toxin, as a 
defense mechanism of cells to processes that lead to cellular proliferation and tumorigenesis, therefore 
triggering apoptosis (Figure 2).  
Another protein putatively involved in MC toxicity is Bcl-2. Lin et al. [65] suggested that Bcl-2 is a 
direct substrate of PP2A and the anti-apoptotic activity of the protein is mediated by phosphorylation 
at the endoplasmic reticulum (ER). The phosphorylated form of the protein is degraded via proteasome 
in the ER leading to the sensitization of cells to several ER related stresses and apoptosis [65]. The 
protein is present in the ER and mitochondria and is likely to be regulated via PP2A or p53. Its 
involvement  in  cell  apoptosis  processes  makes  it  a  putative  player  in  the  mechanisms  of  MC  
toxicity (Figure 2).  
Mitogen-activated protein kinases (MAPKs) regulate the expression of proto-oncogenes which on 
the other hand  regulate the transcription  of genes  involved in  the growth and  differentiation [66]. 
Expression of MAPKs is mediated by PP2A [66] and are likely to be regulated by MC (Figure 2). 
MAPKs were induced in apoptotic HEK293-OATP1B3 cells exposed to MC-LR suggesting for a role 
of these proteins in cell apoptosis mediated by the toxin [67]. The expression of three proto-oncogenes 
c-fos, c-jun and c-myc were reported to increase in liver, kidney and testis of Wistar rats injected 
intravenously  with  MC-LR,  with  higher  levels  registered  in  liver [68].  Expression  of  these  genes, 
pointed by the authors as a possible mechanism for the tumor-promoting activity of the toxin, could be 
controlled by MAPKs. 
3.3. Oxidative Stress 
A biochemical feature of MC toxicity is the production of reactive oxygen species (ROS). This 
ROS  generation  has  been  reported  using  in  vitro  systems  such  as  human  hepatoma  cell  line  
(HepG2) [69], fish cell lines RTG-2 and PLHC-1 [70], lymphocytes [13] and human erythrocytes [71], 
as well as in several in vivo studies in mice and rat liver, heart and reproductive system [72–76]. It is 
intrinsically  related  with  mitochondria  metabolism  and  can  conduct  to  cell  death  by  necrosis  or 
apoptosis and to genotoxicity. Likewise it is believed to be involved in a series of pathologies such as 
impairment of the blood pumping-function of heart [75] and diseases in liver and kidney [73,74]. The 
underlying  mechanisms  of  MC  mediated  ROS  production  and  cell  injury  are  however  poorly 
characterized [74]. Ding et al. [72] first reported the surge of Ca
2+ in the mitochondria of cultured rat 
hepatocytes, as the first event preceding apoptosis induced by MC-LR. The surge of calcium led to the 
onset  of  MPT  with  subsequent  cell  death.  The  onset  of  MPT  represents  an  abrupt  increase  of 
permeability  of  the  inner  mitochondrial  membrane  to  solutes  with  a  molecular  mass  of  less  than  
1,500 Da [77–79]. Following the onset of MPT, three important cellular events can occur (i) elevation 
of ROS formation, (ii) loss of mitochondrial membrane potential (MMP), and (iii) release of apoptotic 
factors from mitochondria, such as cytochrome c, triggering the execution of apoptosis [79]. Thereby 
the authors proposed that mitochondrial Ca
2+ is one of the underlying mechanisms in MC-LR induced 
onset  of  MPT  and  cell  death.  Exposure  of  Carassius  auratus  lymphocytes  in  vitro  to  the  variant  
MC-RR (10 nmol L
−1) caused a massive Ca
2+ influx, elevation of ROS and subsequent disruption of 
mitochondrial membrane potential and depletion of ATP [13]. The study supports the role of Ca
2+ in 
MC activity and MC variants may have similar ways of action. Another plausible mechanism for ROS Int. J. Mol. Sci. 2010, 11                       
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generation is the increase of NADPH oxidase activity. Nong et al. [69] verified the up-regulation of 
the  CYP2E1  mRNA,  an  isoform  of  cytochrome  P450  that  exhibits  NADPH  oxidase  activity, 
concomitant with the oxidative stress in HepG2 cells induced by MC-LR. Recently other molecules 
have been reported to be related with MC-LR mediated mitochondria dysfunction and oxidative stress. 
The pro-apoptotic proteins Bax and Bid were up-regulated in in vivo hepatocytes of mice liver upon 
oxidative stress induced by MC-LR. This up-regulation of the proteins was concomitant with the loss 
of mitochondrial membrane potential and cell apoptosis [73]. It is known that pro-apoptotic proteins 
associate to create pores in mitochondria membrane therefore being capable of inducing MPT [73]. 
Additionally to Ca
2+ and CYP2E1 these proteins are potential players in MC-LR induced oxidative 
stress and cell apoptosis (Figure 2). Moreover it is well-established that oxidative stress can activate 
the c-Jun N-terminal protein kinase (JNK) pathway in the context of various stimuli or diseases [74]. 
The  protein  kinase  may  act  through  downstream  substrates,  such  as  AP-1  and  Bcl-2  family 
molecules [74],  to  induce  apoptosis,  especially  via the  mitochondria-dependent  apoptotic  pathway. 
Likewise  Wei  et  al. [74]  verified  that  JNK  activation  affects  some  crucial  enzymes  of  energy 
metabolism and leads to mitochondria dysfunction induced by MC-LR. Activity of JNK may, in this 
way, contribute significantly to hepatocyte apoptosis and oxidative liver injury by MC-LR. La-Salete 
et al. [80] demonstrated that MC-LR interacts directly with isolated mitochondria of rat kidney. The 
toxin led to a strong decrease of the transmembrane potential as a consequence of the inhibition of 
redox complexes [80]. The results point for a bioenergetic lesion in the mitochondria of kidney cells 
induced by MC-LR which can contribute significantly to the renal injury induced by the toxin. Part of 
the effects reported by the authors can be explained by the direct interaction of the toxin with the 
ATPase and aldehyde dehydrogenase of the mitochondria, as proposed by Mikhailov et al. [81] and  
Chen et al. [82], respectively. Due to the relevance of oxidative stress in MC toxicity, antioxidant 
compounds such as vitamin E and its analog trolox could be considered in prevention and therapy of 
animals exposed to the toxin. The compounds have been shown to quench free radicals, decrease the 
oxidative stress and reduce histological damage in the fish species tilapia exposed to MC [8,83]. 
3.4. Induction of Neutrophil-derived Chemokine 
The excessive activity of leukocytes in lesion areas of the body has been regarded to induce tissue 
injury and microvascular dysfunction. This is the result of the release, by the neutrophils, of proteolytic 
enzymes  and  reactive  oxygen  and  nitrogen  metabolites  which  will  promote  tissue  damage [84]. 
Similarly to the majority of the lesions that occurs in humans and animals, the MC toxicity is also 
characterized  by  the  influx  of  neutrophils  to  affected  organs [85–87].  Nevertheless,  the  role  of 
neutrophils  in  the  pathogenesis  of  MC  has  not  been  established.  Recently  Kujbika  et  al. [88,89] 
proposed that MC function as a chemotactic agent in neuthrophils playing therefore an important role 
in inflammatory responses. MC-LA, MC-YR and MC-LR induced the expression of the chemokines 
interleukin-8 (IL-8) and cytokine-induced neutrophil chemoattractant-2αβ (CINC-2αβ) as well as the 
extracellular ROS levels in in vitro human and rat neutrophils [89]. MC-LR increased the L-selectin 
and β2-integrin chemokines expression in mice leukocytes and all MC variants induced calcium influx 
with different kinetic profiles. Through the evaluation of the leukocyte-endothelial interactions in the 
presence of MC variants, the authors verified that only MC-LR could induce rolling and adherence of Int. J. Mol. Sci. 2010, 11                       
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leukocytes,  increase  of  L-selectin  and  β2-integrin  expression  but  MC-LA,  MC-YR  and  MC-LR 
induced  migration  of  neutrophils  and  calcium  influx  with  different  kinetic  profiles,  therefore 
demonstrating the neutrophil chemotaxis and Ca
2+ mobilization mediated by MC [88]. 
4. MC Biotransformation and Excretion 
Kondo  et  al. [90]  first demonstrated  that  MC could  be  synthetically converted  into  glutathione 
(GSH)  and  cystein  conjugates.  On  examination  of  the  50%  lethal  dose  (LD50)  with  intravenous 
injection using mice, both GSH and Cys conjugates showed reduction in toxicity compared with the 
native toxin. The authors further investigated the hepatic metabolism of MCs in mice and rats. MCs 
and several metabolites were identified in the livers by means of HPLC and Frit-FAB LC/MS. Among 
them, GSH and Cys conjugates of MCs were identified. Another metabolite was detected as a product 
of  epoxidation  followed  by  hydrolysis  and  sulfate  conjugation  in  the  Adda  moiety  and  GSH 
conjugation in the Mdha moiety [90]. The conjugation of GSH with MCs was suggested to play a role 
in the metabolic pathway leading to detoxification of MCs [90]. Pflugmacher et al. [91] showed that 
MC-LR conjugated to glutathione is mediated by soluble glutathione S-transferase in various aquatic 
organisms  ranging  from  plants  (Ceratophyllum  demersum),  invertebrates  (Dreissena  polymorpha, 
Daphnia  magna)  up  to  fish  eggs  and  fish  (Danio  rerio),  stating  that  the  pathway  for  xenobiotic 
metabolism expressed in all major groups of organisms is involved in the detoxication of MC. Zegura 
et al. [92] verified an increase of the levels of reduced GSH during the exposure of HepG2 cells to 
MC-LR,  after  an  initial  decay.  Concomitant  with  this  increase  was  the  expression  of  glutamate-
cysteine ligase (GCL), the rate-limiting enzyme of GSH synthesis indicating an increased rate of the de 
novo synthesis of GSH [92]. Normal or elevated levels of intracellular GSH were correlated with no 
additional DNA damage or the repair of existing damage. The work points out the importance of GSH 
in  the amelioration of MC-LR genotoxicity which can  be explained by its  capacity to  inhibit the 
activity of the toxin by forming MC-GSH conjugates or by its antioxidant activity. In the metabolism 
of  xenobiotics  the  first  reactions  are  catalyzed  by  cytochrome  p450  oxidases  and  GSTs  which 
respectively introduce reactive or polar groups into the xenobiotics and conjugate the modified toxins 
with glutathione. The modified toxins can be further excreted from cells and eliminated through the 
bile system or metabolized in cells prior to its elimination. GST has been the enzyme most studied 
regarding the biotransformation of MC. Nevertheless the underlying pathways and enzymes of MC 
biotransformation/excretion were not identified yet. In mammals, three major families of GSTs have 
been  identified:  the  cytosolic  GSTs  (including  seven  classes,  namely  alpha,  mu,  pi,  theta,  sigma, 
omega, and zeta), the mitochondrial GST (kappa class) and microsomal GSTs [93]. A distinct GST 
isoform, which has no homologues in mammals, was found in fish and named as rho class in red sea 
bream (Pagrus major) [94]. Li et al. [95] studied the GST mRNA abundance in liver, kidney and 
intestine of Goldfish i.p. injected with microcystins extract at two doses (50 and 200 microgkg(-1)BW 
MC-LReq) by real-time PCR. The authors verified that the transcription of GST alpha isoform was 
suppressed in  both  liver  and  intestine,  but  induced  in  the  kidney.  The  transcription  of  GST  theta 
decreased in liver, kidney and intestine in the low-dose group and the transcription of GST pi isoform 
was suppressed in liver and intestine post-injection in both dose groups [95]. The work demonstrates 
that the transcription of GST isoforms varies in different ways within an organ and among organs of Int. J. Mol. Sci. 2010, 11                       
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goldfish exposed to MCs. The relative changes of nine GST genes including cytosolic GSTs (rho, mu, 
theta, alpha and pi), mitochondrial GST (kappa) and microsomal GSTs (mGST1, mGST2 and mGST3) 
were studied after stimulation with MC-LR in the liver of the common carp Cyprinus carpio [96]. 
Increased levels of GST alpha, rho and mGST3 transcripts were detected at 6h post stimulation; the 
mu, theta and mGST2 transcripts were relatively stable; and all the GST transcripts except GST kappa 
and  rho  recovered  to  original  levels  compared  with  controls  at  72  h.  This  work  highlights  the 
importance  of  the  analysis  of  the  different  GSTs  at  different  times  post-stimulation  for  the 
identification  of  the  isoforms  putatively  involved  in  MC  biotransformation [96].  Wang  et  al. [97] 
studied the transcriptional response of liver genes related to phase I and phase II detoxification in the 
Nile tilapia (Oreochromis niloticus) fish exposed to MC-LR via intraperitoneal injection. The authors 
reported the increase in the soluble GST isoform (sGST) mRNA expression but in contrast, the levels 
of  cytochrome  P450  1  A  (CYP1A)  mRNA  expression  were  unchanged  with  MC-LR  treatment 
supporting the putative involvement of the GST and the importance of the phase II in the cyanotoxin 
detoxication through the conjugation pathway [97]. The authors also suggest that hepatocyte proteins 
coping with oxidative stress such as glutathione peroxidase and the uncoupling protein 2 have some 
auxiliary effect. 
Multi-xenobiotic resistance (MXR) is a physiological process analogous to the multidrug resistance 
(MDR)  reported  in  tumor  cells.  It  is  a  defense  mechanism  that  contributes  to  the  decrease  in 
intracellular  concentrations  of  many  unrelated  but  cytotoxic  compounds.  The  processes  are 
characterized by the increase in the expression of multidrug transporters such as the P-glycoprotein  
(P-gp). In mammalian tumor cells this increase of P-gp expression leads to a drop in the accumulation 
of  chemotherapeutical  drugs  as  well  as  the  formation  of  resistant  tumor  cells [98].  P-gp  is  found 
endogenously  in  specialized  epithelial  tissues  involved  in  secretion  and  excretion  such  as  the 
mammalian gut, liver, and kidney, as well as on endothelial cells of capillary blood vessels at the 
blood-brain  barrier [99].  P-gp  acts  as  an  energy-dependent  pump  to  translocate  a  wide  variety  of 
structurally and functionally diverse substrates. These compounds tend to be moderately hydrophobic, 
planar,  natural  products  which  are  often  substrates  or  metabolites  of  the  detoxification  enzymes 
cytochrome P450 and GST [99]. The expression of the human P-gp homologous protein was found to 
increase in gills, liver and brain of the fish species Jenynsia multidentata after exposure to MC-LR, in 
a  time  and  dose  dependent  manner [100].  The  work  indirectly  associates  P-gp  expression  with  a 
defence mechanism to reduce the concentration of the toxin in the fish tissues [100]. The involvement 
of P-gp on the excretion of MC-LR in the freshwater mussel Dreissena polymorpha was evidenced 
through the analysis of P-gp gene expression and the analysis of the efflux and accumulation version 
of the compound rhodamine [101]. P-gp expression was enhanced after 1 h exposure but no changes 
were detected after longer (72 h) exposure. Nevertheless P-gp enzyme activity showed a significant 
increase with exposure time. The concomitant decrease of the concentration of the toxin in the tissues 
of  animals  during  the  72  h  exposure,  after  a  peak  of  accumulation  in  the  first  hour  of  exposure 
indicates that the protein is putatively involved in the excretion of the toxin. Int. J. Mol. Sci. 2010, 11                       
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5. Conclusions 
MC  are  potent  hepatotoxins,  with  genotoxic  properties.  They  are  strong  inhibitors  of  the 
serine/threonine phosphatases PP1 and PP2A. This is probably the main mechanism of action of these 
toxins through which alters cell’s metabolism and triggers a cascade of events leading to the necrosis 
or apoptosis of animal cells (Figure 2). MC regulate the activity of protein kinases by direct PP1 and 
PP2A inhibition. This can have a strong impact in the activity of phosphoproteins, DNA repair systems 
and gene expression. On the other hand the cyclic peptide seems to interact with the mitochondria of 
animal cells triggering the oxidative stress and apoptosis. Moreover the molecule can be inactivated in 
the cells in a process that implicates the conjugation with glutathione (Figure 2). MC toxicity is a 
multi-pathway process and regardless the recent achievements the molecular mechanisms underlying 
MC  toxicity  remain  elusive  and  a  lack  of  knowledge  persists  regarding  the  specific  MC 
target/interacting proteins, the signaling pathways triggering the cell’s response and the downstream 
pathways  of  toxicity  and  cell’s  injury.  In  this  way  complementary  genomics  and  proteomics  are 
promising approaches to achieve a comprehensive characterization of the MC toxicity in animal cells.  
Acknowledgements 
Alexandre Campos work is supported by the Ministé rio da Ciê ncia, Tecnologia e Ensino Superior 
(MCTES) and the European Social Fund.  
References 
1.  Amorim, A.; Vasconcelos, V. Dynamics of microcystins in the mussel Mytilus galloprovincialis. 
Toxicon 1999, 37, 1041–1052. 
2.  Gerard, C.; Carpentier, A.; Paillisson, J.-M. Long-term dynamics and community structure of 
freshwater gastropods exposed to parasitism and other environmental stressors. Freshwater Biol. 
2008, 53, 470–484. 
3.  Gerard,  C.;  Poullain,  V.;  Lance,  E.;  Acou,  A.;  Brient,  L.;  Carpentier,  A.  Influence  of  toxic 
cyanobacteria  on  community  structure  and  microcystin  accumulation  of  freshwater  molluscs. 
Environ. Pollut. 2009, 157, 609–617. 
4.  van Apeldoorn, M.E.; van Egmond, H.P.; Speijers, G.J.; Bakker, G.J. Toxins of cyanobacteria. 
Mol. Nutr. Food Res. 2007, 51, 7–60. 
5.  McElhiney, J.; Lawton, L.A. Detection of the cyanobacterial hepatotoxins microcystins. Toxicol. 
Appl. Pharmacol. 2005, 203, 219–230. 
6.  Feurstein,  D.;  Holst,  K.;  Fischer,  A.;  Dietrich,  D.R.  Oatp-associated  uptake  and  toxicity  of 
microcystins in primary murine whole brain cells. Toxicol. Appl. Pharmacol. 2009, 234, 247–255. 
7.  Puerto,  M.;  Pichardo,  S.;  Jos,  A.;  Camean,  A.M.  Comparison  of  the  toxicity  induced  by 
microcystin-RR and microcystin-YR in differentiated and undifferentiated Caco-2 cells. Toxicon 
2009, 54, 161–169. 
8.  Prieto, A.I.; Jos, A.; Pichardo, S.; Moreno, I.; de Sotomayor, M.A.; Moyano, R.; Blanco, A.; 
Camean,  A.M.  Time-dependent  protective  efficacy  of  Trolox  (vitamin  E  analog)  against Int. J. Mol. Sci. 2010, 11                       
 
 
281 
microcystin-induced  toxicity  in  tilapia  (Oreochromis  niloticus).  Environ.  Toxicol.  2009,  24,  
563–579. 
9.  Song,  W.;  de  la  Cruz,  A.A.;  Rein,  K.;  O'Shea,  K.E.  Ultrasonically  induced  degradation  of 
microcystin-LR and -RR: Identification of products, effect of pH, formation and destruction of 
peroxides. Environ. Sci. Technol. 2006, 40, 3941–3946. 
10.  Tsuji, K.; Naito, S.; Kondo, F.; Ishikawa, N.; Watanabe, M.F.; Suzuki, M.; Harada, K.-I. Stability 
of microcystins from cyanobacteria: Effect of light on decomposition and isomerization. Environ. 
Sci. Technol. 1994, 28, 173–177. 
11.  MacKintosh, C.; Beattie, K.A.; Klumpp, S.; Cohen, P.; Codd, G.A. Cyanobacterial microcystin-
LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and 
higher plants. FEBS Lett. 1990, 264, 187–192. 
12.  Gulledgea, B.M.; Aggena, J.B.; Huangb, H.B.; Nairnc, A.C.; Chamberlin, A.R. The microcystins 
and  nodularins:  Cyclic  polypeptide  inhibitors  of  PP1  and  PP2A.  Curr.  Med.  Chem.  2002,  9,  
1991–2003. 
13.  Zhang, H.; Zhang, J.; Chen, Y.; Zhu, Y. Microcystin-RR induces apoptosis in fish lymphocytes by 
generating reactive oxygen species and causing mitochondrial damage. Fish Physiol. Biochem. 
2008, 34, 307–312. 
14.  Lankoff, A.; Sochacki, J.; Spoof, L.; Meriluoto, J.; Wojcik, A.; Wegierek, A.; Verschaeve, L. 
Nucleotide  excision  repair  impairment  by  nodularin  in  CHO  cell  lines  due  to  ERCC1/XPF 
inactivation. Toxicol. Lett. 2008, 179, 101–107. 
15.  Fujiki, H.; Suganuma, M. Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors. Prog. 
Mol. Subcell Biol. 2009, 46, 221–254. 
16.  Nishiwaki-Matsushima, R.; Ohta, T.; Nishiwaki, S.; Suganuma, M.; Kohyama, K.; Ishikawa, T.; 
Carmichael, W.W.; Fujiki, H. Liver tumor promotion by the cyanobacterial cyclic peptide toxin 
microcystin-LR. J. Cancer Res. Clin. Oncol. 1992, 118, 420–424. 
17.  Falconer, I.R. Tumour promotion and liver injury caused by oral consumption of cyanobacteria. 
Environ. Toxicol. Water Qual. 1991, 6, 177–184. 
18.  Humpage,  A.R.;  Hardy,  S.J.;  Moore,  E.J.;  Froscio,  S.M.;  Falconer,  I.R.  Microcystins 
(cyanobacterial toxins) in drinking water enhance the growth of aberrant crypt foci in the mouse 
colon. J. Toxicol. Environ. Health A 2000, 61, 155–165. 
19.  Milutinović, A.; Živin, M.; Zorc-Plesković, R.; Sedmark, B.; Šuput, D. Nephrotoxic effects of 
chronic administration of microcystins-LR and –YR. Toxicon 2003, 42, 281–288. 
20.  Milutinović, A.; Sedmark, B.; Horvat-ŽnidarŠić, I.; Šuput, D. Renal injuries induced by chronic 
intoxication with microcystins. Cell Mol. Biol. Lett. 2002, 7, 139–141. 
21.  Nobre,  A.C.L.;  Jorge,  M.C.M.;  Menezes,  D.B.;  Fonteles,  M.C.;  Monteiro,  H.S.A.  Effects  of 
microcystin-LR in isolated perfused rat kidney. Braz. J. Med. Biol. Res. 1999, 32, 985–988. 
22.  Botha, N.; Van de Venter, M.; Downing, T.G.; Shepard, E.G.; Gehringer, E.G. The effect of 
intraperitoneally  administered  microcystin-LR  on  the  gastrointestinal  tract  of  Balb/c  mice. 
Toxicon 2004, 43, 251–254. 
23.  Zegura,  B.;  Volcic,  M.;  Lah,  T.T.;  Filipic,  M.  Different  sensitivities  of  human  colon 
adenocarcinoma (CaCo-2), astrocytoma (IPDDC-A2) and lymphoblastoid (NCNC) cell lines to 
microcystin-LR induced reactive oxygen species and DNA damage. Toxicon 2008, 52, 518–525. Int. J. Mol. Sci. 2010, 11                       
 
 
282 
24.  Dias,  E.;  Andrade,  M.;  Alverca,  E.;  Pereira,  P.;  Batoreu,  M.C.;  Jordan,  P.;  Silva,  M.J. 
Comparative  study  of  the  cytotoxic  effect  of  microcistin-LR  and  purified  extracts  from  M. 
aeruginosa on a kidney cell line. Toxicon 2009, 53, 487–495. 
25.  Svircev, Z.; Krstic, S.; Miladinov-Mikov, M.; Baltic, V.; Vidovic, M. Freshwater cyanobacterial 
blooms and primary liver cancer epidemiological studies in Serbia.  J. Environ. Sci. Health C 
Environ. Carcinog. Ecotoxicol. Rev. 2009, 27, 36–55. 
26.  Hernandez, J.M.; Lopez-Rodas, V.; Costas, E. Microcystins from tap water could be a risk factor 
for liver and colorectal cancer: A risk intensified by global change. Med. Hypotheses 2009, 72, 
539–540. 
27.  Ueno, Y.; Nagata, S.; Tsutsumi, T.; Hasegawa, A.; Watanabe, M.F.; Park, H.D.; Chen, G.C.; 
Chen, G.; Yu, S.Z. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water 
sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive 
immunoassay. Carcinogenesis 1996, 17, 1317–1321. 
28.  Herfindal,  L.;  Selheim,  F.,  Microcystin  produces  disparate  effects  on  liver  cells  in  a  dose 
dependent manner. Mini Rev. Med. Chem. 2006, 6, 279–285. 
29.  Pearson, L.A.; Moffitt, M.C.; Ginn, H.P.; Neilan, B.A. The molecular genetics and regulation of 
cyanobacterial peptide hepatotoxin biosynthesis. Crit. Rev. Toxicol. 2008, 38, 847–856. 
30.  Tillett,  D.;  Dittmann,  E.;  Erhard,  M.;  von  Dohren,  H.;  Borner,  T.;  Neilan,  B.A.  Structural 
organization  of  microcystin  biosynthesis  in  Microcystis  aeruginosa  PCC7806:  An  integrated 
peptide-polyketide synthetase system. Chem. Biol. 2000, 7, 753–764. 
31.  Young, F.M.; Thomson, C.; Metcalf, J.S.; Lucocq, J.M.; Codd, G.A. Immunogold localisation of 
microcystins in cryosectioned cells of Microcystis. J. Struct. Biol. 2005, 151, 208–214. 
32.  Juttner, F.; Luthi, H. Topology and enhanced toxicity of bound microcystins in Microcystis PCC 
7806. Toxicon 2008, 51, 388–397. 
33.  Eriksson, J.E.; Gronberg, L.; Nygard, S.; Slotte, J.P.; Meriluoto, J.A. Hepatocellular uptake of 3H-
dihydromicrocystin-LR, a cyclic peptide toxin. Biochim. Biophys. Acta 1990, 1025, 60–66. 
34.  Klaassen,  C.D.;  Lu,  H.  Xenobiotic  transporters:  Ascribing  function  from  gene  knockout  and 
mutation studies. Toxicol. Sci. 2008, 101, 186–196. 
35.  Trauner,  M.;  Boyer,  J.L.  Bile  salt  transporters:  Molecular  characterization,  function,  and 
regulation. Physiol. Rev. 2003, 83, 633–671. 
36.  Fischer, W.J.; Altheimer, S.; Cattori, V.; Meier, P.J.; Dietrich, D.R.; Hagenbuch, B. Organic anion 
transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol. 
Appl. Pharmacol. 2005, 203, 257–263. 
37.  Meier-Abt, F.; Hammann-Hanni, A.; Stieger, B.; Ballatori, N.; Boyer, J.L. The organic anion 
transport polypeptide 1d1 (Oatp1d1) mediates hepatocellular uptake of phalloidin and microcystin 
into skate liver. Toxicol. Appl. Pharmacol. 2007, 218, 274–279. 
38.  Lu, H.; Choudhuri, S.; Ogura, K.; Csanaky, I.L.; Lei, X.; Cheng, X.; Song, P.Z.; Klaassen, C.D. 
Characterization of organic anion transporting polypeptide 1b2-null mice: Essential role in hepatic 
uptake/toxicity of phalloidin and microcystin-LR. Toxicol. Sci. 2008, 103, 35–45. Int. J. Mol. Sci. 2010, 11                       
 
 
283 
39.  Maynes, J.T.; Luu, H.A.; Cherney, M.M.; Andersen, R.J.; Williams, D.; Holmes, C.F.; James, 
M.N. Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: 
Elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins. J. Mol. Biol. 2006, 
356, 111–120. 
40.  Yoshizawa, S.; Matsushima, R.; Watanabe, M.F.; Harada, K.; Ichihara, A.; Carmichael, W.W.; 
Fujiki,  H.  Inhibition  of  protein  phosphatases  by  microcystins  and  nodularin  associated  with 
hepatotoxicity. J. Cancer Res. Clin. Oncol. 1990, 116, 609–614. 
41.  Honkanen, R.E.; Zwiller, J.; Moore, R.E.; Daily, S.L.; Khatra, B.S.; Dukelow, M.; Boynton, A.L. 
Characterization  of  microcystin-LR,  a  potent  inhibitor  of  type  1  and  type  2A  protein 
phosphatases. J. Biol. Chem. 1990, 265, 19401–19404. 
42.  Craig, M.; Luu, H.A.; McCready, T.L.; Williams, D.; Andersen, R.J.; Holmes, C. F. Molecular 
mechanisms underlying he interaction of motuporin and microcystins with type-1 and type-2A 
protein phosphatases. Biochem. Cell Biol. 1996, 74, 569–578. 
43.  Goldberg,  J.;  Huang,  H.B.;  Kwon,  Y.G.;  Greengard,  P.;  Nairn,  A.C.;  Kuriyan,  J.  Three-
dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature 
1995, 376, 745–753. 
44.  Dawson, J.F.; Holmes, C.F. Molecular mechanisms underlying inhibition of protein phosphatases 
by marine toxins. Front. Biosci. 1999, 4, D646–D658. 
45.  Xing, Y.; Xu, Y.; Chen, Y.; Jeffrey, P.D.; Chao, Y.; Lin, Z.; Li, Z.; Strack, S.; Stock, J.B.; Shi, Y. 
Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell 2006, 127, 
341–353. 
46.  Ohta,  T.;  Nishiwaki,  R.;  Yatsunami,  J.;  Komori,  A.;  Suganuma,  M.;  Fujiki,  H. 
Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, 
in primary cultured rat hepatocytes. Carcinogenesis 1992, 13, 2443–2447.  
47.  Wickstrom,  M.L.;  Khan,  S.A.;  Haschek,  W.M.;  Wyman,  J.F.;  Eriksson,  J.E.;  Schaeffer,  D.J.; 
Beasley, V.R. Alterations in microtubules, intermediate filaments, and microfilaments induced by 
microcystin-LR in cultured cells. Toxicol. Pathol. 1995, 23, 326–337. 
48.  Falconer, I.R.; Yeung, D.S. Cytoskeletal changes in hepatocytes induced by Microcystis toxins 
and  their  relation  to  hyperphosphorylation  of  cell  proteins.  Chem.  Biol.  Interact.  1992,  81,  
181–196. 
49.  Douglas,  P.;  Moorhead,  G.B.;  Ye,  R.;  Lees-Miller,  S.P.  Protein  phosphatases  regulate  DNA-
dependent protein kinase activity. J. Biol. Chem. 2001, 276, 18992–18998. 
50.  Lankoff, A.; Bialczyk, J.; Dziga, D.; Carmichael, W.W.; Lisowska, H.; Wojcik, A. Inhibition of 
nucleotide  excision  repair  (NER)  by  microcystin-LR  in  CHO-K1  cells.  Toxicon  2006,  48,  
957–965. 
51.  Ariza,  R.R.;  Keyse,  S.M.;  Moggs,  J.G.;  Wood,  R.D.  Reversible  protein  phosphorylation 
modulates nucleotide excision repair of damaged DNA by human cell extracts. Nucl. Acid. Res. 
1996, 24, 433–440. 
52.  Fladmark,  K.E.;  Brustugun,  O.T.;  Hovland,  R.;  Boe,  R.;  Gjertsen,  B.T.;  Zhivotovsky,  B.; 
Doskeland,  S.O.  Ultrarapid  caspase-3  dependent  apoptosis  induction  by  serine/threonine 
phosphatase inhibitors. Cell Death Differ. 1999, 6, 1099–1108. Int. J. Mol. Sci. 2010, 11                       
 
 
284 
53.  Fladmark,  K.E.;  Brustugun,  O.T.;  Mellgren,  G.;  Krakstad,  C.;  Boe,  R.;  Vintermyr,  O.K.; 
Schulman,  H.;  Doskeland,  S.O.  Ca
2+/calmodulin-dependent  protein  kinase  II  is  required  for 
microcystin-induced apoptosis. J. Biol. Chem. 2002, 277, 2804–2811. 
54.  Ding, W.X.; Ong, C.N. Role of oxidative stress and mitochondrial changes in cyanobacteria-
induced apoptosis and hepatotoxicity. FEMS Microbiol. Lett. 2003, 220, 1–7. 
55.  Ding, W.X.; Shen, H.M.; Ong, C.N. Critical role of reactive oxygen species and mitochondrial 
permeability  transition  in  microcystin-induced  rapid  apoptosis  in  rat  hepatocytes.  Hepatology 
2000, 32, 547–555. 
56.  Krakstad, C.; Herfindal, L.; Gjertsen, B.T.; Boe, R.; Vintermyr, O.K.; Fladmark, K.E.; Doskeland, 
S.O. CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell 
budding,  but  not  to  shrinkage  or  chromatin  hypercondensation.  Cell  Death  Differ.  2006,  13,  
1191–1202. 
57.  Hayward, D.G.; Fry, A.M. Nek2 kinase in chromosome instability and cancer. Cancer Lett. 2006, 
237, 155–166. 
58.  Li, M.; Satinover, D.L.; Brautigan, D.L. Phosphorylation and functions of inhibitor-2 family of 
proteins. Biochemistry 2007, 46, 2380–2389. 
59.  Fu, W.Y.; Chen, J.P.; Wang, X.M.; Xu, L.H. Altered expression of p53, Bcl-2 and Bax induced 
by microcystin-LR in vivo and in vitro. Toxicon 2005, 46, 171–177. 
60.  Li,  H.-H.;  Cai,  X.;  Shouse,  G.P.;  Piluso,  L.G.;  Liu,  X.  A  specific  PP2A  regulatory  subunit, 
B56[gamma],  mediates  DNA  damage-induced  dephosphorylation  of  p53  at  Thr55.  EMBO  J. 
2007, 26, 402–411. 
61.  Xing, M.L.; Wang, X.F.; Xu, L.H. Alteration of proteins expression in apoptotic FL cells induced 
by MCLR. Environ. Toxicol. 2008, 23, 451–458. 
62.  Zegura, B.; Zajc, I.; Lah, T.T.; Filipic, M. Patterns of microcystin-LR induced alteration of the 
expression  of  genes  involved  in  response  to  DNA  damage  and  apoptosis.  Toxicon  2008,  51,  
615–623. 
63.  Morselli, E.; Galluzzi, L.; Kroemer, G. Mechanisms of p53-mediated mitochondrial membrane 
permeabilization. Cell Res. 2008, 18, 708–710. 
64.  Clark, S.P.; Ryan, T.P.; Searfoss, G.H.; Davis, M.A.; Hooser, S.B. Chronic microcystin exposure 
induces hepatocyte proliferation with increased expression of mitotic and cyclin-associated genes 
in P53-deficient mice. Toxicol. Pathol. 2008, 36, 190–203. 
65.  Lin,  S.S.;  Bassik,  M.C.;  Suh,  H.;  Nishino,  M.;  Arroyo,  J.D.;  Hahn,  W.C.;  Korsmeyer,  S.J.; 
Roberts, T.M. PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at 
the endoplasmic reticulum. J. Biol. Chem. 2006, 281, 23003–23012. 
66.  Gehringer, M.M. Microcystin-LR and okadaic acid-induced cellular effects: A dualistic response. 
FEBS Lett. 2004, 557, 1–8. 
67.  Komatsu, M.; Furukawa, T.; Ikeda, R.; Takumi, S.; Nong, Q.; Aoyama, K.; Akiyama, S.; Keppler, 
D.;  Takeuchi,  T.  Involvement  of  mitogen-activated  protein  kinase  signaling  pathways  in 
microcystin-LR-induced  apoptosis  after  its  selective  uptake  mediated  by  OATP1B1  and 
OATP1B3. Toxicol. Sci. 2007, 97, 407–416. Int. J. Mol. Sci. 2010, 11                       
 
 
285 
68.  Li, H.; Xie, P.; Li, G.; Hao, L.; Xiong, Q. In vivo study on the effects of microcystin extracts on 
the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of 
male Wistar rats injected i.v. with toxins. Toxicon 2009, 53, 169–175. 
69.  Nong, Q.; Komatsu, M.; Izumo, K.; Indo, H.P.; Xu, B.; Aoyama, K.; Majima, H. J.; Horiuchi, M.; 
Morimoto, K.; Takeuchi, T. Involvement of reactive oxygen species in Microcystin-LR-induced 
cytogenotoxicity. Free Radic. Res. 2007, 41, 1326–1337. 
70.  Pichardo, S.; Jos, A.; Zurita, J.L.; Salguero, M.; Camean, A.M.; Repetto, G. Acute and subacute 
toxic effects produced by microcystin-YR on the fish cell lines RTG-2 and PLHC-1. Toxicol. 
Vitro 2007, 21, 1460–1467. 
71.  Sicinska,  P.;  Bukowska,  B.;  Michalowicz,  J.;  Duda,  W.  Damage  of  cell  membrane  and 
antioxidative  system  in  human  erythrocytes  incubated  with  microcystin-LR  in  vitro.  Toxicon 
2006, 47, 387–397. 
72.  Ding, W.X.; Shen, H.M.; Ong, C.N. Pivotal role of mitochondrial Ca(
2+) in microcystin-induced 
mitochondrial permeability transition in rat hepatocytes. Biochem. Biophys. Res. Commun. 2001, 
285, 1155–1161. 
73.  Weng,  D.;  Lu,  Y.;  Wei,  Y.;  Liu,  Y.;  Shen,  P.  The  role  of  ROS  in  microcystin-LR-induced 
hepatocyte apoptosis and liver injury in mice. Toxicology 2007, 232, 15–23. 
74.  Wei, Y.; Weng, D.; Li, F.; Zou, X.; Young, D.O.; Ji, J.; Shen, P. Involvement of JNK regulation 
in  oxidative  stress-mediated  murine  liver  injury  by  microcystin-LR.  Apoptosis  2008,  13,  
1031–1042. 
75.  Qiu, T.; Xie, P.; Liu, Y.; Li, G.; Xiong, Q.; Hao, L.; Li, H. The profound effects of microcystin on 
cardiac antioxidant enzymes, mitochondrial function and cardiac toxicity in rat. Toxicology 2009, 
257, 86–94. 
76.  Li, Y.; Sheng, J.; Sha, J.; Han, X. The toxic effects of microcystin-LR on the reproductive system 
of male rats in vivo and in vitro. Reproduct. Toxicol. 2008, 26, 239–245. 
77.  Crompton, M. The mitochondrial permeability transition pore and its role in cell death. Biochem. 
J. 1999, 341, 233–249. 
78.  Bernardi, P.; Scorrano, L.; Colonna, R.; Petronilli, V.; Di Lisa, F. Mitochondria and cell death. 
Mechanistic aspects and methodological issues. Eur. J. Biochem. 1999, 264, 687–701. 
79.  Lemasters, J.J.; Nieminen, A.L.; Qian, T.; Trost, L.C.; Elmore, S.P.; Nishimura, Y.; Crowe, R.A.; 
Cascio,  W.E.;  Bradham,  C.A.;  Brenner,  D.A.;  Herman,  B.  The  mitochondrial  permeability 
transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim. 
Biophys. Acta 1998, 1366, 177–196. 
80.  La-Salete, R.; Oliveira, M.M.; Palmeira, C.A.; Almeida, J.; Peixoto, F.P. Mitochondria a key role 
in microcystin-LR kidney intoxication. J. Appl. Toxicol. 2008, 28, 55–62. 
81.  Mikhailov, A.; Hä rmä lä -Braské n, A.-S.; Hellman, J.; Meriluoto, J.; Eriksson, J. E. Identification 
of ATP-synthase as a novel intracellular target for microcystin-LR. Chem. Biol. Interact. 2003, 
142, 223–237. 
82.  Chen, T.; Cui, J.; Liang, Y.; Xin, X.; Young, D.O.; Chen, C.; Shen, P. Identification of human 
liver mitochondrial aldehyde dehydrogenase as a potential target for microcystin-LR. Toxicology 
2006, 220, 71–80. Int. J. Mol. Sci. 2010, 11                       
 
 
286 
83.  Prieto, A.I.; Jos, A.; Pichardo, S.; Moreno, I.; Camean, A.M. Protective role of vitamin E on the 
microcystin-induced  oxidative  stress  in  tilapia  fish  (Oreochromis  niloticus).  Environ.  Toxicol. 
Chem. 2008, 27, 1152–1159. 
84.  Babior, B.M. Phagocytes and oxidative stress. Am. J. Med. 2000, 109, 33–44. 
85.  Carmichael, W.W.; Azevedo, S.M.; An, J.S.; Molica, R.J.; Jochimsen, E.M.; Lau, S.; Rinehart, 
K.L.;  Shaw,  G.R.;  Eaglesham,  G.K.  Human  fatalities  from  cyanobacteria:  Chemical  and 
biological evidence for cyanotoxins. Environ. Health Perspect 2001, 109, 663–668. 
86.  Jochimsen,  E.M.;  Carmichael,  W.W.;  An,  J.S.;  Cardo,  D.M.;  Cookson,  S.T.;  Holmes,  C.E.; 
Antunes, M.B.; Filho, D.A.M.; Lyra, T.M.; Barreto, V.S.; Azevedo, S.M.; Jarvis, W.R. Liver 
failure and death after exposure to microcystins at a hemodialysis center in Brazil. N. Engl. J. 
Med. 1998, 338, 873–878. 
87.  Pouria, S.; de Andrade, A.; Barbosa, J.; Cavalcanti, R.L.; Barreto, V.T.; Ward, C.J.; Preiser, W.; 
Poon,  G.K.;  Neild,  G.H.;  Codd,  G.A.  Fatal  microcystin  intoxication  in  haemodialysis  unit  in 
Caruaru, Brazil. Lancet 1998, 352, 21–26. 
88.  Kujbida, P.; Hatanaka, E.; Vinolo, M.A.; Waismam, K.; Cavalcanti, D.M.; Curi, R.; Farsky, S.H.; 
Pinto, E. Microcystins -LA, -YR, and -LR action on neutrophil migration. Biochem. Biophys. Res. 
Commun. 2009, 382, 9–14. 
89.  Kujbida, P.; Hatanaka, E.; Campa, A.; Curi, R.; Farsky, S.H.P.; Pinto, E. Analysis of chemokines 
and reactive oxygen species formation by rat and human neutrophils induced by microcystin-LA, 
-YR and -LR. Toxicon 2008, 51, 1274–1280. 
90.  Kondo, F.; Ikai, Y.; Oka, H.; Okumura, M.; Ishikawa, N.; Harada, K.; Matsuura, K.; Murata, H.; 
Suzuki, M. Formation, characterization, and toxicity of the glutathione and cysteine conjugates of 
toxic heptapeptide microcystins. Chem. Res. Toxicol. 1992, 5, 591–596. 
91.  Pflugmacher, S.; Wiegand, C.; Oberemm, A.; Beattie, K.A.; Krause, E.; Codd, G. A.; Steinberg, 
C.E.W.  Identification  of  an  enzymatically  formed  glutathione  conjugate  of  the  cyanobacterial 
hepatotoxin microcystin-LR: The first step of detoxication. Biochim. Biophys. Acta (BBA): Gen. 
Subj. 1998, 1425, 527–533. 
92.  Zegura,  B.;  Lah,  T.T.;  Filipic,  M.  Alteration  of  intracellular  GSH  levels  and  its  role  in 
microcystin-LR-induced DNA damage in human hepatoma HepG2 cells. Mutat. Res. 2006, 611, 
25–33. 
93.  Hayes,  J.D.;  Flanagan,  J.U.;  Jowsey,  I.R.  Glutathione  transferases.  Annu.  Rev.  Pharmacol. 
Toxicol. 2005, 45, 51–88. 
94.  Konishi, T.; Kato, K.; Araki, T.; Shiraki, K.; Takagi, M.; Tamaru, Y. A new class of glutathione 
S-transferase from the hepatopancreas of the red sea bream Pagrus major. Biochem. J. 2005, 388, 
299–307. 
95.  Li, G.; Xie, P.; Fu, J.; Hao, L.; Xiong, Q.; Li, H. Microcystin-induced variations in transcription 
of GSTs in an omnivorous freshwater fish, goldfish. Aquat. Toxicol. 2008, 88, 75-80. 
96.  Fu,  J.;  Xie,  P.  The  acute  effects  of  microcystin  LR  on  the  transcription  of  nine  glutathione  
S-transferase genes in common carp Cyprinus carpio L. Aquat. Toxicol. 2006, 80, 261–266. Int. J. Mol. Sci. 2010, 11                       
 
 
287 
97.  Wang,  L.;  Liang,  X.F.;  Liao,  W.Q.;  Lei,  L.M.;  Han,  B.P.  Structural  and  functional 
characterization of microcystin detoxification-related liver genes in a phytoplanktivorous fish, 
Nile tilapia (Oreochromis niloticus).  Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2006, 
144, 216–227. 
98.  Toomey, B.H.; Epel, D. A multixenobiotic transporter in Urechis caupo embryos:  Protection 
from pesticides? Mar. Environ. Res. 1995, 39, 299–302. 
99.  Bard, S.M. Multixenobiotic resistance as a cellular defense mechanism in aquatic organisms. 
Aquat. Toxicol. 2000, 48, 357–389. 
100.  Ame, M.V.; Baroni, M.V.; Galanti, L.N.; Bocco, J.L.; Wunderlin, D.A. Effects of microcystin-
LR  on  the  expression  of  P-glycoprotein  in  Jenynsia  multidentata.  Chemosphere  2009,  74,  
1179–1186. 
101.  Contardo-Jara,  V.;  Pflugmacher,  S.;  Wiegand,  C.  Multi-xenobiotic-resistance  a  possible 
explanation for the insensitivity of bivalves towards cyanobacterial toxins. Toxicon 2008, 52, 
936–943. 
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. 
This  article  is  an  open-access  article  distributed  under  the  terms  and  conditions  of  the  Creative 
Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). 